PL2912186T3 - Leczenie ukierunkowane na płytki krwi - Google Patents
Leczenie ukierunkowane na płytki krwiInfo
- Publication number
- PL2912186T3 PL2912186T3 PL13848463T PL13848463T PL2912186T3 PL 2912186 T3 PL2912186 T3 PL 2912186T3 PL 13848463 T PL13848463 T PL 13848463T PL 13848463 T PL13848463 T PL 13848463T PL 2912186 T3 PL2912186 T3 PL 2912186T3
- Authority
- PL
- Poland
- Prior art keywords
- targeted treatment
- platelet
- platelet targeted
- treatment
- targeted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261717951P | 2012-10-24 | 2012-10-24 | |
PCT/US2013/066651 WO2014066663A1 (en) | 2012-10-24 | 2013-10-24 | Platelet targeted treatment |
EP13848463.9A EP2912186B1 (en) | 2012-10-24 | 2013-10-24 | Platelet targeted treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2912186T3 true PL2912186T3 (pl) | 2021-06-14 |
Family
ID=50545271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13848463T PL2912186T3 (pl) | 2012-10-24 | 2013-10-24 | Leczenie ukierunkowane na płytki krwi |
Country Status (13)
Country | Link |
---|---|
US (3) | US9982034B2 (pl) |
EP (2) | EP2912186B1 (pl) |
JP (2) | JP2016501515A (pl) |
KR (1) | KR101819803B1 (pl) |
BR (1) | BR112015009229B1 (pl) |
CA (1) | CA2888982C (pl) |
DK (1) | DK2912186T3 (pl) |
ES (1) | ES2854754T3 (pl) |
HK (1) | HK1211986A1 (pl) |
IL (1) | IL238417B (pl) |
PL (1) | PL2912186T3 (pl) |
WO (1) | WO2014066663A1 (pl) |
ZA (1) | ZA201502945B (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11319528B2 (en) | 2015-07-13 | 2022-05-03 | University Of Utah Research Foundation | Methods of making red blood cells and platelets in vitro and uses thereof |
EP3861102A4 (en) * | 2018-10-05 | 2022-07-13 | University of Utah Research Foundation | METHODS OF MAKING BOARDS COMPRISING MODIFIED RECEPTORS AND USES THEREOF |
WO2020113090A1 (en) | 2018-11-30 | 2020-06-04 | Cellphire, Inc. | Platelets as delivery agents |
WO2020112963A1 (en) | 2018-11-30 | 2020-06-04 | Cellphire, Inc. | Platelets as delivery agents |
WO2020186193A1 (en) * | 2019-03-13 | 2020-09-17 | Cellphire, Inc. | Canine blood platelet preparations |
BR112021021984A2 (pt) | 2019-05-03 | 2022-03-03 | Cellphire Inc | Materiais e métodos para produzir produtos de sangue |
BR112022002892A2 (pt) | 2019-08-16 | 2022-05-24 | Cellphire Inc | Trombossomos como um agente de reversão de agente antiplaqueta |
US20210308185A1 (en) | 2020-02-04 | 2021-10-07 | Cellphire, Inc. | Methods of treating acquired hemophilia with anti-fibrinolytic loaded platelets |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2452892A (en) | 1947-05-07 | 1948-11-02 | Robert A Appleton | Igniter for rockets |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
IT1253009B (it) | 1991-12-31 | 1995-07-10 | Sclavo Ricerca S R L | Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini |
ES2143716T3 (es) | 1992-06-25 | 2000-05-16 | Smithkline Beecham Biolog | Composicion de vacuna que contiene adyuvantes. |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
DE69535036T3 (de) | 1994-07-15 | 2011-07-07 | The University of Iowa Research Foundation, IA | Immunomodulatorische oligonukleotide |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US7184826B2 (en) | 1996-06-18 | 2007-02-27 | Alza Corporation | Device and method for enhancing transdermal flux of agents being delivered or sampled |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
KR100453132B1 (ko) | 1996-12-20 | 2004-10-15 | 앨자 코포레이션 | 경피 약제 플럭스를 향상시키기 위한 장치 및 방법 |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
DE69815692T2 (de) | 1997-09-05 | 2004-04-29 | Glaxosmithkline Biologicals S.A. | Öl in wasser emulsionen mit saponinen |
GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
CA2312900A1 (en) | 1997-12-02 | 1999-06-10 | Powderject Vaccines, Inc. | Transdermal delivery of particulate vaccine compositions |
EP1048736A1 (en) * | 1999-04-27 | 2000-11-02 | Aventis Behring Gesellschaft mit beschränkter Haftung | DNA-construct for the tissue specific expression of a blood coagulation factor |
NZ530131A (en) * | 2001-06-15 | 2005-12-23 | Andre C | Gene therapy for hemophilia A |
US7629153B2 (en) * | 2001-08-02 | 2009-12-08 | Research Development Foundation | Methods and compositions relating to improved lentiviral vector production systems |
AU2002347062B2 (en) | 2001-10-06 | 2008-06-26 | Merial Ltd | CpG formulations and related methods |
US7417026B2 (en) | 2003-08-13 | 2008-08-26 | Children's Hospital Medical Center | Mobilization of hematopoietic cells |
NZ554895A (en) | 2004-11-03 | 2009-06-26 | Almac Diagnostics Ltd | Transcriptome microarray technology and methods of using the same |
KR100981092B1 (ko) | 2008-02-29 | 2010-09-08 | 고려대학교 산학협력단 | 제8 혈액응고 인자와 폰 빌리 블란트 인자 변이체의 재조합발현 벡터 시스템 |
WO2010075303A1 (en) | 2008-12-23 | 2010-07-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same |
US8147820B2 (en) | 2009-09-14 | 2012-04-03 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Attenuated vaccine against fish pathogen Francisella sp |
BR112012011740A2 (pt) * | 2009-11-13 | 2018-03-27 | Grifols Therapeutics Inc | polipeptídeo, composição compreendendo o referido polipeptídeo, complexo de proteína, seqüência de nucleotídeo, vetor de expressão célula, e métodos para a preparação do complexo de proteína, para a preparação de um fviii, e para intensificar uma propriedade farmacocinética no plasma de um fviii |
US20120225028A1 (en) | 2011-03-02 | 2012-09-06 | Moshe Cohen | Compositions and methods for mobilization of stem cells |
-
2013
- 2013-10-24 EP EP13848463.9A patent/EP2912186B1/en active Active
- 2013-10-24 CA CA2888982A patent/CA2888982C/en active Active
- 2013-10-24 KR KR1020157012821A patent/KR101819803B1/ko active IP Right Grant
- 2013-10-24 BR BR112015009229-2A patent/BR112015009229B1/pt active IP Right Grant
- 2013-10-24 EP EP21150184.6A patent/EP3859004A1/en active Pending
- 2013-10-24 JP JP2015539804A patent/JP2016501515A/ja active Pending
- 2013-10-24 DK DK13848463.9T patent/DK2912186T3/da active
- 2013-10-24 US US14/437,457 patent/US9982034B2/en active Active
- 2013-10-24 PL PL13848463T patent/PL2912186T3/pl unknown
- 2013-10-24 ES ES13848463T patent/ES2854754T3/es active Active
- 2013-10-24 WO PCT/US2013/066651 patent/WO2014066663A1/en active Application Filing
-
2015
- 2015-04-21 IL IL238417A patent/IL238417B/en active IP Right Grant
- 2015-04-29 ZA ZA2015/02945A patent/ZA201502945B/en unknown
- 2015-12-30 HK HK15112856.1A patent/HK1211986A1/xx unknown
-
2017
- 2017-08-29 US US15/689,875 patent/US10294291B2/en active Active
-
2018
- 2018-07-19 JP JP2018135886A patent/JP6975105B2/ja active Active
-
2019
- 2019-03-22 US US16/361,591 patent/US20190270791A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2912186A1 (en) | 2015-09-02 |
DK2912186T3 (da) | 2021-02-22 |
JP2016501515A (ja) | 2016-01-21 |
KR20150069017A (ko) | 2015-06-22 |
IL238417B (en) | 2019-07-31 |
CA2888982C (en) | 2020-07-21 |
KR101819803B1 (ko) | 2018-01-17 |
BR112015009229B1 (pt) | 2021-07-20 |
IL238417A0 (en) | 2015-06-30 |
JP2018161152A (ja) | 2018-10-18 |
EP3859004A1 (en) | 2021-08-04 |
ZA201502945B (en) | 2016-11-30 |
US20180009874A1 (en) | 2018-01-11 |
ES2854754T3 (es) | 2021-09-22 |
HK1211986A1 (en) | 2016-06-03 |
BR112015009229A2 (pt) | 2017-11-14 |
EP2912186B1 (en) | 2021-01-06 |
US20190270791A1 (en) | 2019-09-05 |
WO2014066663A1 (en) | 2014-05-01 |
JP6975105B2 (ja) | 2021-12-01 |
US20150344541A1 (en) | 2015-12-03 |
EP2912186A4 (en) | 2016-06-08 |
US9982034B2 (en) | 2018-05-29 |
CA2888982A1 (en) | 2014-05-01 |
US10294291B2 (en) | 2019-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211475A1 (en) | Combination therapy | |
EP2916795A4 (en) | IMPROVED ROLLATOR | |
EP2819703A4 (en) | TREATMENT OF PAIN | |
EP2921192A4 (en) | CATHETER | |
EP2906208A4 (en) | THERAPEUTIC TREATMENT | |
EP2872120A4 (en) | TARGETED THERAPEUTIC NANOPARTICLES | |
EP2823767A4 (en) | CATHETER | |
EP2862620A4 (en) | SYSTEM FOR TREATING DISCHARGE GAS | |
EP2926857A4 (en) | CATHETER | |
HK1211986A1 (en) | Platelet targeted treatment | |
GB2521289B (en) | Formation treatment system | |
GB201217439D0 (en) | Combination therapy | |
EP2777576A4 (en) | TREATMENT SYSTEM | |
EP2803328A4 (en) | TREATMENT SYSTEM | |
EP2789306A4 (en) | TREATMENT SYSTEM | |
EP2864362A4 (en) | ANTICANCER TREATMENT | |
GB201207305D0 (en) | Therapy | |
HK1210426A1 (en) | Combination therapy | |
EP2810680A4 (en) | CATHETER | |
EP2804853A4 (en) | THERAPEUTIC USES | |
EP2704731A4 (en) | TREATMENT OF AVIAN ORIGIN | |
GB201211135D0 (en) | Treatment | |
GB201208690D0 (en) | Treatment | |
GB201212604D0 (en) | New treatment | |
EP2900310A4 (en) | MULTI-WINDING CATHETER |